期刊文献+

尿激酶静脉溶栓治疗急性ST段抬高型心肌梗死疗效观察

下载PDF
导出
摘要 目的探讨对急性ST段抬高型心肌梗死患者采用尿激酶静脉溶栓治疗的临床疗效。方法选取我院2013年—2014年收治的50例急性ST段抬高型心肌梗死患者作为研究对象,随机分为对照组和观察组,每组各25例。对照组行常规溶栓治疗,观察组行尿激酶静脉溶栓治疗,比较2组临床疗效及不良反应。结果观察组5 h内再通13例(52.00%),总再通19例(76.00%),并发症发生率为12.00%;对照组5 h内再通5例(20.00%),总再通7例(28.00%),并发症发生率为52.00%。观察组5 h内再通率、总再通率显著高于对照组,差异均有统计学意义(P<0.05);观察组并发症发生率显著低于对照组,差异有统计学意义(P<0.05)。结论在急性ST段抬高型心肌梗死治疗中,采用尿激酶静脉溶栓治疗的临床疗效确切,减少了不良反应的发生,提高了血管再通率,值得临床推广应用。
作者 张晓辉
机构地区 岐山县医院
出处 《基层医学论坛》 2015年第20期2781-2782,共2页 The Medical Forum
  • 相关文献

参考文献8

二级参考文献36

  • 1杨艳敏,朱俊,谭慧琼,梁岩,章晏,李建东,刘力生,CREATE中国课题组.中国ST段抬高的急性心肌梗死临床特征及治疗现状[J].中华医学杂志,2005,85(31):2176-2182. 被引量:85
  • 2Sabatine MS, Cannon CP, Gibson CM, et al. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST - segment elevation [J]. N Engl J Med, 2005, 352 (12) : 1179-1189.
  • 3Antman EM, Smith SC, Mpert JS, et al. ACC/AHA guidelines for the management of patients with ST - elevation myocardial infarction - executive summary [J]. Circulation, 2004, 110:588 -636.
  • 4Bhatt D, Topol E. Clopidogrel added to aspirin versus aspirin alone in secondary prevention and high - risk primary prevention: rationale and design of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial [ J]. Am Heart J, 2004, 148 (2): 263-268.
  • 5COMMIT (CIOpidogrel and Metoprolol in Myocardial Infarction Trial) collaborative group. Early intravenous then oral metoprolol in 45852 patients with acute muocardial infarction : randomised placebo - controlled trial [J]. Lancet, 2005, 366 (17): 1607-1632.
  • 6Collaborative Research Group of Reperfusion Therapy in Acute Myocardial Infarction.重组葡激酶与重组组织型纤溶酶原激活剂治疗急性心肌梗死的随机多中心临床试验[J].中华心血管病杂志,2007,35(8):691-696. 被引量:43
  • 7The collaborative study group for national multicenter clinical trial of urokinase thrombolytic therapy (Correspondence: Hu Dayi, Xu Zhimin. Beijing Red Cross Chao Yao Hospital, Beijing 100020).尿激酶治疗急性心肌梗塞多中心临床试验1406例总结[J].中华心血管病杂志,1997,25(3):176-179. 被引量:138
  • 8Rose AM, Gao R, Coyne KS, et al. A randomized trial confir- ming the efficacy of reduced dose recombinant tissue plasminogen activator in a Chinese myocardial infarction population and dem- onstrating superiority to usual 'dose urokinase: the TUCC trial [J]. Am HeartJ, 2001, 142 (2): 244-247.
  • 9The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial in- farction[J]. N EngJ Med, 1993, 329 (10): 673-682.
  • 10王爱平,王占启,尹博英,等.瑞替普酶静脉注射治疗急性心肌梗死66例[J].临床医药,2008,17(5):251-253.

共引文献141

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部